Add BrightSurf on Google Email

Journal of the National Cancer Institute


Common therapy for HIV associated with cervical abnormality regression

A study by Johns Hopkins Bloomberg School of Public Health found that Highly Active Antiretroviral Therapy (HAART) improved the regression rates of cervical squamous intraepithelial lesions (SIL) in HIV-positive women. However, a significant proportion of high-risk lesions persisted even among those who received HAART.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 20, 2004

High-dose chemotherapy not superior to conventional chemotherapy in high-risk breast cancer patients

A randomized trial of 605 patients with four or more positive lymph nodes found no difference in 5-year relapse-free survival and overall survival between conventional and high-dose chemotherapy. High-dose chemotherapy was shown to confer extra cost and toxicity without added anticancer benefit.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 20, 2004

Other highlights in the July 21 JNCI

A study analyzing the Surveillance, Epidemiology, and End Results (SEER) database found that it is reasonably reliable for collecting cancer incidence and mortality data. Researchers compared histologic tumor types from patients reported to the SEER database with those obtained through an independent review, finding no difference in di...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 20, 2004

Other highlights in the July 7 JNCI

A new study found that most phase I studies of targeted, non-cytotoxic anticancer agents used traditional toxicity endpoints to determine the recommended dose, while non-traditional endpoints were rarely incorporated. Researchers also identified a potential mechanism for acrylamide's mutagenicity and discovered genetic polymorphisms as...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 6, 2004

Other highlights in the June 16 JNCI

A new study by Cancer Research UK found that common mutations in genes regulating estrogen metabolism are not associated with breast cancer risk. However, a separate study suggests that inhibition of hypoxia-inducible factor 1alpha (HIF-1alpha) activity may be a target for future gastric cancer treatments.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 15, 2004

'Reduced exposure' tobacco products lessen carcinogen exposure, but medicinal nicotine better

A study found that users of reduced exposure tobacco products experienced decreased levels of nitrosamines in their urine after switching, with medicinal nicotine groups showing greater reductions. However, the actual reduction in carcinogen exposure for OMNI cigarette users was less than advertised.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 1, 2004

Different methods of adjuvant chemotherapy for colorectal cancer have similar outcomes

A randomized clinical trial found that regional and systemic adjuvant chemotherapy regimens had similar survival rates for colon cancer patients, with the combination regimen offering no added benefit. The study, published in the Journal of the National Cancer Institute, also showed lower adverse reaction rates for regional therapy.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 18, 2004

Other highlights in the May 19 JNCI

Researchers discovered feasible chemotherapy combinations that include trastuzumab for HER2-positive advanced breast cancer, with higher overall response rates and lower cardiac dysfunction. Two phase II clinical trials showed promising results, paving the way for future randomized phase III trials.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 18, 2004

Clinic-based intervention program improves smoking cessation rates, study says

A randomized, controlled trial among 2163 adult smokers at eight primary care clinics found that clinicians following the AHRQ Guideline offered more assistance to those who wished to quit. This led to improved rates of smoking cessation, with test site patients reporting abstinence from smoking at higher rates than control site patients.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 20, 2004

Other highlights in the April 21 JNCI

A survey of oncologists and nurses found that while most agree to offer trial results to patients, only 62% actually do so due to concerns over potential negative effects, patient interpretation, and resource consumption. Additionally, a new study demonstrates tamoxifen's association with reduced breast density, particularly in younger...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 20, 2004

Other highlights in the April 7 JNCI

Two new studies found no association between aspirin use and mortality from pancreatic cancer, while elevated insulin production was linked to an increased risk of colorectal cancer. Hyperinsulinemia, a condition associated with type 2 diabetes, also appears to be linked to an increased risk of colorectal cancer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 6, 2004

Treatment of ductal carcinoma in situ varies widely in United States

The study found that 97.5% of patients with DCIS underwent surgery, but there is a wide variation in treatment approaches, including the use of mastectomy, radiation therapy, and axillary dissection. The incidence of DCIS increased by 73% between 1992 and 1999, highlighting the need for standardized treatment recommendations.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMar 16, 2004

Other highlights in the February 4 issue of JNCI

Researchers discuss the need for additional research and standardization in partial-breast irradiation and accelerated partial-breast irradiation. A new study also finds that preoperative chemoradiation may benefit some patients with rectal cancer, while a diet high in glycemic load is linked to an increased risk of colorectal cancer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateFeb 3, 2004

Exposure to carcinogens not proportionally decreased by reduction in smoking

A recent study found that reducing cigarette consumption by 25%, 50%, and 75% did not proportionally decrease the levels of carcinogens in smokers' urine. Despite a reduction in cigarettes smoked per day, NNK metabolites remained relatively stable. The authors suggest that people may compensate for reduced smoking by inhaling longer an...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJan 20, 2004

Study supports tailoring adjuvant therapy for early-stage breast cancer

A new study suggests that premenopausal women with ER-negative breast cancer may benefit from adjuvant chemotherapy alone or followed by goserelin, while those with ER-positive tumors show no significant difference in outcomes. The findings support the idea of ovarian suppression as a treatment alternative for some premenopausal women.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 16, 2003

Oral drug showing promise for breast cancer prevention in a mouse model

Researchers found that oral drug ZD1839 suppressed the growth of ER-negative breast cancer cells and delayed the formation of tumors in transgenic mice. The treatment also reduced proliferation of normal breast cells by 20.3% and tumor cells by 42%. However, long-term safety data are needed for further research.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 16, 2003

Other highlights in the December 17 issue of JNCI

Researchers identified frequent BRAF mutations in intermittent sun-exposed skin melanomas, but rare mutations in chronically sun-damaged or unseen skin. Additionally, bladder cancer cell lines showed defective checkpoint function, suggesting barriers to carcinogenesis. These findings may inform therapeutic strategies for these diseases.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 16, 2003

Study suggests US stop smoking effort paying off

A study of the American Stop Smoking Intervention Study (ASSIST) found that states participating in the program experienced a greater reduction in adult smoking prevalence and lower per capita cigarette consumption compared to non-participating states. If all 50 states had implemented ASSIST, an estimated 278,700 fewer smokers nationwi...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 18, 2003

High nuclear grade associated with recurrence of in situ breast lesions

A study of 1,036 women with ductal carcinoma in situ (DCIS) diagnosed at age 40 or older found that those with high-nuclear-grade lesions had a higher risk of invasive cancer recurrence. Women treated by lumpectomy alone who experienced initial palpation-detected lesions also faced a greater risk of recurrence.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 18, 2003